nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—ADRB2—autistic disorder	0.911	1	CbGaD
Metipranolol—Esmolol—ADRB2—autistic disorder	0.00109	0.14	CrCbGaD
Metipranolol—Atenolol—ADRB2—autistic disorder	0.000949	0.122	CrCbGaD
Metipranolol—Pindolol—HTR1B—autistic disorder	0.000919	0.118	CrCbGaD
Metipranolol—Acebutolol—ADRB2—autistic disorder	0.000876	0.112	CrCbGaD
Metipranolol—Oxprenolol—ADRB2—autistic disorder	0.000869	0.112	CrCbGaD
Metipranolol—Alprenolol—ADRB2—autistic disorder	0.000795	0.102	CrCbGaD
Metipranolol—Metoprolol—ADRB2—autistic disorder	0.000739	0.0948	CrCbGaD
Metipranolol—Pindolol—ADRB2—autistic disorder	0.000684	0.0878	CrCbGaD
Metipranolol—Propranolol—HTR1B—autistic disorder	0.000502	0.0644	CrCbGaD
Metipranolol—Propranolol—ADRB2—autistic disorder	0.000373	0.0479	CrCbGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKCB—autistic disorder	0.000168	0.00206	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	0.000167	0.00205	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—GABBR1—autistic disorder	0.000165	0.00203	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—ADM—autistic disorder	0.000165	0.00203	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKCB—autistic disorder	0.000164	0.00202	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	0.000163	0.00201	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—OPRM1—autistic disorder	0.000159	0.00196	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—autistic disorder	0.000158	0.00194	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR5A—autistic disorder	0.000158	0.00194	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—OPRM1—autistic disorder	0.000155	0.00191	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR5A—autistic disorder	0.000154	0.0019	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GABBR2—autistic disorder	0.000148	0.00182	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GABBR2—autistic disorder	0.000144	0.00178	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR1B—autistic disorder	0.000141	0.00174	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—OXT—autistic disorder	0.000141	0.00174	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR1B—autistic disorder	0.000138	0.0017	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—OXT—autistic disorder	0.000138	0.0017	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—autistic disorder	0.000135	0.00166	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GABBR2—autistic disorder	0.000134	0.00165	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1D—autistic disorder	0.000131	0.00162	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD1—autistic disorder	0.000131	0.00161	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GABBR2—autistic disorder	0.000131	0.00161	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1D—autistic disorder	0.000129	0.00158	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD1—autistic disorder	0.000128	0.00158	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD3—autistic disorder	0.000127	0.00156	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	0.000127	0.00156	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD3—autistic disorder	0.000124	0.00153	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	0.000124	0.00153	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—autistic disorder	0.000123	0.00152	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CALCA—autistic disorder	0.000123	0.00151	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GRM8—autistic disorder	0.000122	0.00151	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—autistic disorder	0.000121	0.00148	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CALCA—autistic disorder	0.00012	0.00148	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GRM8—autistic disorder	0.00012	0.00147	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1D—autistic disorder	0.000119	0.00147	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1D—autistic disorder	0.000117	0.00144	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PDE4A—autistic disorder	0.000115	0.00142	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PDE4A—autistic disorder	0.000112	0.00139	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GRM8—autistic disorder	0.000111	0.00137	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GRM8—autistic disorder	0.000109	0.00134	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AVPR1A—autistic disorder	0.000108	0.00133	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—WNT2—autistic disorder	0.000107	0.00132	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	0.000106	0.0013	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AVPR1A—autistic disorder	0.000105	0.0013	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—WNT2—autistic disorder	0.000105	0.0013	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PDE4A—autistic disorder	0.000104	0.00129	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GRM5—autistic disorder	0.000104	0.00128	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—VIP—autistic disorder	0.000104	0.00128	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	0.000103	0.00127	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—ADRB2—autistic disorder	0.000103	0.00127	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PDE4A—autistic disorder	0.000102	0.00126	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GRM5—autistic disorder	0.000102	0.00125	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—VIP—autistic disorder	0.000102	0.00125	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—OXTR—autistic disorder	0.000101	0.00124	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—SCT—autistic disorder	9.96e-05	0.00123	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—OXTR—autistic disorder	9.85e-05	0.00121	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AVPR1A—autistic disorder	9.77e-05	0.0012	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—SCT—autistic disorder	9.75e-05	0.0012	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NRP2—autistic disorder	9.71e-05	0.0012	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—AVP—autistic disorder	9.66e-05	0.00119	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AVPR1A—autistic disorder	9.56e-05	0.00118	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GABBR1—autistic disorder	9.5e-05	0.00117	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ADM—autistic disorder	9.5e-05	0.00117	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NRP2—autistic disorder	9.5e-05	0.00117	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—AVP—autistic disorder	9.45e-05	0.00116	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GRM5—autistic disorder	9.44e-05	0.00116	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—VIP—autistic disorder	9.44e-05	0.00116	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR5A—autistic disorder	9.31e-05	0.00115	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GABBR1—autistic disorder	9.3e-05	0.00115	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—ADM—autistic disorder	9.3e-05	0.00115	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PDE4B—autistic disorder	9.26e-05	0.00114	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GRM5—autistic disorder	9.23e-05	0.00114	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—VIP—autistic disorder	9.23e-05	0.00114	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—OXTR—autistic disorder	9.14e-05	0.00113	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR5A—autistic disorder	9.1e-05	0.00112	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PDE4B—autistic disorder	9.06e-05	0.00112	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—SCT—autistic disorder	9.05e-05	0.00111	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—OPRM1—autistic disorder	8.97e-05	0.00111	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—OXTR—autistic disorder	8.94e-05	0.0011	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—SCT—autistic disorder	8.85e-05	0.00109	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—OPRM1—autistic disorder	8.78e-05	0.00108	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GABBR1—autistic disorder	8.63e-05	0.00106	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ADM—autistic disorder	8.63e-05	0.00106	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—ADM—autistic disorder	8.44e-05	0.00104	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GABBR1—autistic disorder	8.44e-05	0.00104	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	8.43e-05	0.00104	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PDE4B—autistic disorder	8.41e-05	0.00104	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	8.25e-05	0.00102	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PDE4B—autistic disorder	8.23e-05	0.00101	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—OPRM1—autistic disorder	8.15e-05	0.001	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR2A—autistic disorder	8.04e-05	0.00099	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—OPRM1—autistic disorder	7.97e-05	0.000982	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1B—autistic disorder	7.97e-05	0.000981	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—OXT—autistic disorder	7.97e-05	0.000981	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GABBR2—autistic disorder	7.91e-05	0.000975	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR2A—autistic disorder	7.86e-05	0.000969	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—OXT—autistic disorder	7.79e-05	0.00096	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1B—autistic disorder	7.79e-05	0.00096	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GABBR2—autistic disorder	7.74e-05	0.000954	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD1—autistic disorder	7.4e-05	0.000912	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD1—autistic disorder	7.24e-05	0.000892	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1B—autistic disorder	7.23e-05	0.000891	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—OXT—autistic disorder	7.23e-05	0.000891	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD3—autistic disorder	7.17e-05	0.000884	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—OXT—autistic disorder	7.08e-05	0.000872	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1B—autistic disorder	7.08e-05	0.000872	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1D—autistic disorder	7.05e-05	0.000869	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—IL5—autistic disorder	7.02e-05	0.000865	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD3—autistic disorder	7.02e-05	0.000864	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CALCA—autistic disorder	6.93e-05	0.000854	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1D—autistic disorder	6.9e-05	0.00085	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—IL5—autistic disorder	6.87e-05	0.000846	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRLR—autistic disorder	6.79e-05	0.000836	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CALCA—autistic disorder	6.78e-05	0.000836	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD1—autistic disorder	6.72e-05	0.000829	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRLR—autistic disorder	6.64e-05	0.000818	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD1—autistic disorder	6.58e-05	0.00081	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM8—autistic disorder	6.56e-05	0.000808	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD3—autistic disorder	6.51e-05	0.000802	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—POMC—autistic disorder	6.42e-05	0.000791	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM8—autistic disorder	6.41e-05	0.00079	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL5—autistic disorder	6.37e-05	0.000785	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD3—autistic disorder	6.37e-05	0.000785	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—WNT2—autistic disorder	6.35e-05	0.000782	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CALCA—autistic disorder	6.3e-05	0.000776	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—POMC—autistic disorder	6.28e-05	0.000774	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GHR—autistic disorder	6.25e-05	0.000771	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL5—autistic disorder	6.24e-05	0.000768	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—WNT2—autistic disorder	6.21e-05	0.000765	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PDE4A—autistic disorder	6.16e-05	0.00076	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CALCA—autistic disorder	6.16e-05	0.000759	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GHR—autistic disorder	6.12e-05	0.000754	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	6.03e-05	0.000743	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	5.81e-05	0.000716	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	5.77e-05	0.000711	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	5.65e-05	0.000696	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM5—autistic disorder	5.57e-05	0.000687	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—VIP—autistic disorder	5.57e-05	0.000687	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	5.46e-05	0.000673	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM5—autistic disorder	5.45e-05	0.000672	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—VIP—autistic disorder	5.45e-05	0.000672	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—OXTR—autistic disorder	5.4e-05	0.000665	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SCT—autistic disorder	5.34e-05	0.000659	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	5.34e-05	0.000658	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—OXTR—autistic disorder	5.28e-05	0.000651	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	5.28e-05	0.00065	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SCT—autistic disorder	5.23e-05	0.000644	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	5.1e-05	0.000628	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADM—autistic disorder	5.1e-05	0.000628	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	5.01e-05	0.000617	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADM—autistic disorder	4.99e-05	0.000615	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	4.99e-05	0.000615	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	4.97e-05	0.000612	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AVP—autistic disorder	4.96e-05	0.000611	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	4.9e-05	0.000604	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	4.86e-05	0.000599	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AVP—autistic disorder	4.85e-05	0.000598	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	4.81e-05	0.000593	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	4.71e-05	0.00058	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	4.66e-05	0.000574	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	4.56e-05	0.000562	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	4.54e-05	0.00056	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	4.44e-05	0.000547	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GZMB—autistic disorder	4.4e-05	0.000542	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GZMB—autistic disorder	4.31e-05	0.00053	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	4.27e-05	0.000526	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—OXT—autistic disorder	4.27e-05	0.000526	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—OXT—autistic disorder	4.18e-05	0.000515	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	4.18e-05	0.000515	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	4.13e-05	0.000508	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	4.04e-05	0.000497	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	3.98e-05	0.000491	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TSC1—autistic disorder	3.97e-05	0.000489	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD1—autistic disorder	3.97e-05	0.000489	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	3.9e-05	0.00048	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TSC1—autistic disorder	3.89e-05	0.000479	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD1—autistic disorder	3.89e-05	0.000479	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	3.86e-05	0.000476	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD3—autistic disorder	3.85e-05	0.000474	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	3.81e-05	0.00047	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	3.78e-05	0.000466	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL5—autistic disorder	3.77e-05	0.000464	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD3—autistic disorder	3.76e-05	0.000464	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	3.73e-05	0.000459	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CALCA—autistic disorder	3.72e-05	0.000458	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL5—autistic disorder	3.68e-05	0.000454	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CALCA—autistic disorder	3.64e-05	0.000448	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	3.63e-05	0.000447	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	3.62e-05	0.000446	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	3.55e-05	0.000437	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	3.54e-05	0.000436	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	3.46e-05	0.000426	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	3.39e-05	0.000417	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—POMC—autistic disorder	3.29e-05	0.000406	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRL—autistic disorder	3.29e-05	0.000405	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—POMC—autistic disorder	3.22e-05	0.000397	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRL—autistic disorder	3.21e-05	0.000396	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	3.12e-05	0.000384	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AVP—autistic disorder	2.93e-05	0.000361	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IGF2—autistic disorder	2.92e-05	0.000359	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AVP—autistic disorder	2.86e-05	0.000353	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IGF2—autistic disorder	2.85e-05	0.000351	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	2.75e-05	0.000339	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	2.69e-05	0.000332	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	2.68e-05	0.00033	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	2.68e-05	0.00033	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	2.62e-05	0.000323	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	2.62e-05	0.000323	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	2.61e-05	0.000322	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	2.55e-05	0.000315	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	2.44e-05	0.0003	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL2—autistic disorder	2.44e-05	0.0003	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	2.38e-05	0.000294	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL2—autistic disorder	2.38e-05	0.000294	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TSC2—autistic disorder	2.31e-05	0.000285	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOE—autistic disorder	2.27e-05	0.000279	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LEP—autistic disorder	2.27e-05	0.000279	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TSC2—autistic disorder	2.26e-05	0.000279	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LEP—autistic disorder	2.22e-05	0.000273	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOE—autistic disorder	2.22e-05	0.000273	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	2.14e-05	0.000263	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	2.09e-05	0.000257	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APC—autistic disorder	2.04e-05	0.000252	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	2.04e-05	0.000252	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—EGF—autistic disorder	2.02e-05	0.000249	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APC—autistic disorder	2e-05	0.000246	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	2e-05	0.000246	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.98e-05	0.000244	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.95e-05	0.00024	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.9e-05	0.000235	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.87e-05	0.000231	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.86e-05	0.00023	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.83e-05	0.000226	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.82e-05	0.000225	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.78e-05	0.000219	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	1.74e-05	0.000214	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.5e-05	0.000184	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.46e-05	0.00018	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.44e-05	0.000177	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.43e-05	0.000176	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.41e-05	0.000173	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.4e-05	0.000173	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.35e-05	0.000167	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.32e-05	0.000163	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	1.1e-05	0.000136	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	1.08e-05	0.000133	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HRAS—autistic disorder	8.84e-06	0.000109	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HRAS—autistic disorder	8.64e-06	0.000106	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6—autistic disorder	8.46e-06	0.000104	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6—autistic disorder	8.27e-06	0.000102	CbGpPWpGaD
